Clinical Trials Directory

Trials / Completed

CompletedNCT02090803

Assessment of Human Herpes Virus Reactivation 6 Post Autologous Stem Cells

Assessment of Human Herpes Virus Reactivation 6 Post Autologous Stem Cells , Prospective, Open, Multicenter Study

Status
Completed
Phase
Study type
Observational
Enrollment
189 (actual)
Sponsor
Institut de Cancérologie de la Loire · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the human herpes virus reactivation 6 post autologous stem cells in 196 patients. The aim of our study was to describe the incidence of reactivation of HHV-6 in patients requiring autologous HSCT and determine the pathogenic role in this target population.

Conditions

Timeline

Start date
2012-08-01
Primary completion
2015-03-01
Completion
2015-03-01
First posted
2014-03-18
Last updated
2017-09-14

Locations

3 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02090803. Inclusion in this directory is not an endorsement.

Assessment of Human Herpes Virus Reactivation 6 Post Autologous Stem Cells (NCT02090803) · Clinical Trials Directory